Telik Company Profile

10:44 EDT 20th September 2017 | BioPortfolio

Telik, Inc. (Nasdaq: TELK) of Palo Alto, CA is a biopharmaceutical company dedicated to discovering, developing and commercializing novel small molecule drugs to treat cancer and other serious diseases. Our most advanced development candidate is TELCYTA™ (TLK286), a novel cancer cell-activated chemotherapeutic currently in four Phase 3 registration trials in advanced ovarian cancer and non-small cell lung cancer. A second development candidate, TELINTRA™ (TLK199), is in a Phase 2 clinical trial in myelodysplastic syndrome and may also have utility in the treatment of additional blood disorders characterized by low levels of blood cells. We developed our product candidates through the use of our proprietary TRAP™ technology, which enables the rapid and efficient discovery of small molecule drug candidates. In addition to our internal drug development programs, we partner with select academic institutions and pharmaceutical and biotechnology companies to apply TRAP™ to new drug development programs for a range of diseases. We intend to commercialize our cancer products in North America, and to partner with multinational pharmaceutical companies to assist in the commercialization of our cancer products in other territories.


3165 Porter Drive
Palo Alto
United States of America


Phone: 650-845-7700
Fax: 650-845-7800

News Articles [2 Associated News Articles listed on BioPortfolio]

Telik Announces Orphan Designation Of Telintra® For Treatment Of Myelodysplastic Syndrome

PALO ALTO, Calif., Jan. 11, 2013 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) was notified today that its product candidate, ezatiostat HCL (Telintra), has been granted orphan drug designati...

Telik Announces Second Quarter 2013 Financial Results

PALO ALTO, Calif., Aug. 9, 2013 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) today reported a net loss of $1.4 million, or $0.30 per share, for the second quarter ended June 30, 2013, compared...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Telik, Inc.

Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and developing small molecule drugs to treat cancer. The company's most advanced drug candidates in c...


Telik, Inc. (Nasdaq: TELK) of Palo Alto, CA is a biopharmaceutical company dedicated to discovering, developing and commercializing novel small molecule drugs to treat cancer and other serious disease...

More Information about "Telik" on BioPortfolio

We have published hundreds of Telik news stories on BioPortfolio along with dozens of Telik Clinical Trials and PubMed Articles about Telik for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Telik Companies in our database. You can also find out about relevant Telik Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record